Genmab Archives -

Genmab axes development of AXL-targeting cancer drug enapotamab vedotin

https://pharmaphorum.com/news/genmab-axes-development-axl-targeting-cancer-drug-enapotamab-vedotin/

AbbVie forges $3.9 billion oncology alliance with Genmab

https://pharmaphorum.com/news/abbvie-forges-3-9-billion-oncology-alliance-with-genmab/

J&J defends Darzalex with FDA approval for faster dosing

https://pharmaphorum.com/news/jj-defends-darzalex-with-fda-approval-for-faster-dosing/

Denmark’s Genmab raises a bumper $500m-plus in Nasdaq IPO

https://pharmaphorum.com/news/denmarks-genmab-raises-a-bumper-500m-plus-in-nasdaq-ipo/

Denmark’s Genmab prepares for $500m US IPO

https://pharmaphorum.com/news/denmarks-genmab-prepares-for-500m-us-ipo/

‘Trojan horse’ cancer drug shows promise in multiple tumour types

https://pharmaphorum.com/news/trojan-horse-cancer-drug-shows-promise-multiple-tumour-types/

J&J rumoured to be sizing up $12bn Genmab acquisition

https://pharmaphorum.com/news/jj-buy-danish-biotech-genmab/

Novartis’ Arzerra gains CLL approval

https://pharmaphorum.com/news/novartis-arzerra-gets-new-us-cll-use/

Search